COVID-19 triggered encephalopathic crisis in a patient with glutaric aciduria type 1
Author:
Zubarioglu Tanyel1, Ahmadzada Saffa1, Yalcinkaya Cengiz2, Kiykim Ertugrul1, Aktuglu-Zeybek Cigdem1
Affiliation:
1. Cerrahpasa Medical Faculty, Department of Pediatrics, Division of Nutrition and Metabolism , Istanbul University-Cerrahpasa , Istanbul , Turkey 2. Cerrahpasa Medical Faculty, Department of Neurology, Division of Pediatric Neurology , Istanbul University-Cerrahpasa , Istanbul , Turkey
Abstract
Abstract
Objectives
The impact of coronavirus disease-19 (COVID-19) on metabolic outcome in patients with inborn errors of metabolism has rarely been discussed. Herein, we report a case with an acute encephalopathic crisis at the course of COVID-19 disease as the first sign of glutaric aciduria type 1 (GA-1).
Case presentation
A 9-month-old patient was admitted with encephalopathy and acute loss of acquired motor skills during the course of COVID-19 disease. She had lethargy, hypotonia, and choreoathetoid movements. In terms of COVID-19 encephalopathy, the reverse transcription-polymerase chain reaction assay test for COVID-19 was negative in cerebral spinal fluid. Brain imaging showed frontotemporal atrophy, bilateral subcortical and periventricular white matter, basal ganglia, and thalamic involvement. Elevated glutarylcarnitine in plasma and urinary excretion of glutaric and 3-OH-glutaric acids was noted. A homozygote mutation in the glutaryl-CoA dehydrogenase gene led to the diagnosis of GA-1.
Conclusions
With this report, neurological damage associated with COVID-19 has been reported in GA-1 patients for the first time in literature.
Publisher
Walter de Gruyter GmbH
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology, and Child Health
Reference10 articles.
1. Hoffmann, GF, Kölker, S. Clinical approach to inborn errors of metabolism in pediatrics. In: Saudubray, JM, Baumgartner, MR, Walter, J, editors Inborn metabolic diseases diagnosis and treatment. Heidelberg: Springer; 2016:339–42 pp. 2. Sauer, SW, Okun, JG, Schwab, MA, Crnic, LR, Hoffmann, GH, Goodman, SI, et al.. Bioenergetics in glutaryl-coenzyme A dehydrogenase deficiency: a role for glutaryl-coenzyme A. J Biol Chem 2005;280:21830–6. https://doi.org/10.1074/jbc.m502845200. 3. Larson, A, Goodman, S. Glutaric acidemia type 1. In: Adam, MP, Ardinger, HH, Pagon, RA, Wallace, SE, Bean, LJH, Mirzaa, G, et al.., editors GeneReviews. [Internet]. Seattle, WA: University of Washington; 1993–2021. 4. Boy, N, Mühlhausen, C, Maier, EM, Heringer, J, Assmann, B, Burgard, P, et al.. Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision. J Inherit Metab Dis 2017;40:75–101. https://doi.org/10.1007/s10545-016-9999-9. 5. Kılavuz, S, Bulut, D, Kor, D, Şeker-Yılmaz, B, Özcan, N, Incecik, F, et al.. The outcome of 41 late-diagnosed Turkish GA-1 patients: a candidate for the Turkish NBS. Neuropediatrics 2021;52:358–69. https://doi.org/10.1055/s-0040-1722691.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|